The budget agreement reached in April by Congress and President Obama for the remainder of the 2011 fiscal year (FY) includes major cuts to several key federal health agencies from their FY 2010 funding levels. Among the affected health agencies and programs relevant to IDSA members:
- Centers for Disease Control and Prevention (CDC): $730 million cut (11.4 percent) from the FY 2010 funding level. This represents CDC’s lowest funding level since 2003, when adjusted to include anti-terrorism funding, which is now part of CDC’s base budget. It is currently unknown whether specific centers or programs will bear the majority of the cuts or whether reductions will be applied across the entire CDC budget.
- National Institutes of Health (NIH): $260 million cut (0.8 percent) from FY 2010 level.
- The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR): $23.2 million reduction from FY 2010. The Global Fund to Fight AIDS, Tuberculosis, and Malaria was also cut by $2.1 million compared to FY 2010. Global family planning and reproductive health services were reduced by $85 million from current funding levels.
- While the Prevention and Public Health Fund created under the health care reform law remains intact for FY 2011, it continues to be at risk as some lawmakers view the fund as a way to offset other budgetary cuts rather than as a supplement to the base funding for public health agencies and programs, as the fund was intended.
Among the few spending increases in the budget outside of defense is funding for the Food and Drug Administration (FDA), which will see an increase of $107 million (4 percent) from FY 2010 levels. The AIDS Drug Assistance Program (ADAP) will also receive an additional $25 million over what was allocated in FY 2010.
For more on the budget’s impact on domestic HIV/AIDS and global health funding, see the April 2011 issue of HIVMA enews and Science Speaks, the blog of the Center for Global Health Policy. Several op-eds written by IDSA and HIVMA members encouraging Congress to preserve global health funding were also recently published in several newspapers (see related article in this issue).
In related budget news, earlier this month, IDSA provided testimony (PDF) on the federal budget for the 2012 fiscal year to the House Appropriations Committee covering CDC, NIH, and the Biomedical Advanced Research and Development Authority. IDSA noted the Society’s support for strong funding levels for ID efforts within each of the agencies—particularly on antibiotic resistance.
< Previous Article | Next Article >